Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Other financing activities (2021 - 2023)

Celularity (CELU) has disclosed Other financing activities for 3 consecutive years, with $260000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Other financing activities rose 12.55% to $260000.0 in Q3 2023 year-over-year; TTM through Dec 2023 was $341000.0, a 93.32% decrease, with the full-year FY2023 number at $1.6 million, down 40.36% from a year prior.
  • Other financing activities was $260000.0 for Q3 2023 at Celularity, up from -$150000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $4.8 million in Q1 2021 to a low of -$150000.0 in Q4 2022.
  • A 3-year average of $1.6 million and a median of $999000.0 in 2021 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: tumbled 110.5% in 2022, then grew 12.55% in 2023.
  • Celularity's Other financing activities stood at $1.4 million in 2021, then tumbled by 110.5% to -$150000.0 in 2022, then surged by 273.33% to $260000.0 in 2023.
  • Per Business Quant, the three most recent readings for CELU's Other financing activities are $260000.0 (Q3 2023), -$150000.0 (Q4 2022), and $231000.0 (Q3 2022).